New Publication from the Trevigen Research Team: 

In Vitro Microtumors Provides a Physiologically Predictive Tool for Breast Cancer Therapeutic Screening 

Trevigen Recieves $202,050 Phase I SBIR Grant to Develop a Platform for Functional DNA Repair Measurements

press release

Trevigen Awarded $1,500,000 Phase II SBIR Grant to Bring to Market the CometChip™: a Multi-Purpose High- Throughput Platform for DNA Damage and Repair Quantitation

press release